Human T-cell Kv1.3 potassium channel blockers: New strategies for immunosuppression

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 6, 2000, Pages 905-915

  Lew, A ^a   Chamberlin, A R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Correolide; Immunosuppressant; Non peptidyl blockers; Peptidyl blockers; Scorpion toxin

Indexed keywords

1 BENZYL 1,4 DIHYDRO 4 PENTYLIMINOQUINOLINE; 4 BENZHYDRYLOXYMETHYL 1 [3 (4 METHOXYPHENYL)PROPYL]PIPERIDINE; COELENTERATE VENOM; CORREOLIDE; CP 393223; CP 393224; CP 394322; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; KALIOTOXIN; MARGATOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RAPAMYCIN; STILBENE DERIVATIVE; TACROLIMUS; UNCLASSIFIED DRUG; WIN 17317 3;

DRUG STRUCTURE; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; NEUROTOXICITY; REVIEW; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 0034120436     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.6.905     Document Type: Review

References (46)